The evidence chain
Commitment -> Priority -> Capability -> Programme -> Capital -> Implementation -> Output -> Outcome -> Progress. Each edge was evaluated independently using frozen definitions.
Explore the evidence
Every edge in the evidence chain was evaluated independently.
Traceable
Two or more independent sources, an explicit link and no counterevidence.
Partial
Evidence exists, but the chain is incomplete or supported by fewer than two independent sources.
Not assessed
No identifiable public evidence after systematic search.
Broken
An independent source shows an explicit problem with enough detail to quantify the break.
Public evidence traceability across 10 countries
The chain is strongest at Commitment -> Priority and weakens toward Outcome -> Progress.
Commitment -> Priority10 T
Priority -> Capability8 T
Capability -> Programme6 T
Programme -> Capital1 T
Capital -> Implementation6 T
Implementation -> Output7 T
Output -> Outcome1 T
Outcome -> Progress0 T
TraceablePartialNot assessedBroken
Not a ranking. This measures public evidence availability, not AMR performance.
Not a ranking
Country differences reflect public reporting environments and source coverage. A country may have strong AMR work that is simply not publicly reconstructable from the reviewed sources.
Country explorer
Each country is shown as a public evidence chain, not as a score.
The sample covers different regions, income groups and source-coverage environments. The result is a traceability map, not an implementation ranking.
Ghana
5/8 traceable2 not assessed
Bangladesh
3/8 traceable3 not assessed
Sri Lanka
1/8 traceable4 not assessed
Nigeria
5/8 traceable2 not assessed
India
4/8 traceable3 not assessed
Thailand
5/8 traceable1 not assessed
United Kingdom
7/8 traceable0 not assessed
Ethiopia
1/8 traceable5 not assessed
Philippines
5/8 traceable3 not assessed
Peru
1/8 traceable3 not assessed
< Back to country explorer
Ghana
AFRO · LMIC · high source coverage
These findings measure public evidence traceability, not the quality or effectiveness of national AMR implementation.
5Traceable
2Not assessed
HighSource coverage
Commitment -> Priority
TraceableConfidence: A
Source: NAP Ghana 2017-2021 + WHO TrACSS 2023
Priority -> Capability
TraceableConfidence: B
Capability -> Programme
TraceableConfidence: B
Programme -> Capital
PartialConfidence: C
Source: Fleming Fund / MTaPS reports. Donor-funded activity is visible; domestic AMR attribution remains unclear.
Capital -> Implementation
TraceableConfidence: B
Implementation -> Output
TraceableConfidence: B
Output -> Outcome
Not assessedConfidence: D
Why not assessed: GLASS 2023 reports surveillance data, but no outcome linkage studies were identified in the reviewed public evidence.
Outcome -> Progress
Not assessedConfidence: D
Why not assessed: No systematic AMR outcome or progress metrics were found in the reviewed public sources.
Methodology and reproducibility
Frozen definitions before analysis, visible caveats after analysis.
The methodology was frozen before the country assessment began. Definitions were pre-specified and not modified during analysis, reducing hindsight bias and preserving reproducibility.
Methodologybc6841c3f...
Sample7622ba652...
Released1eda9cba...
Frozen methodology v2.1
- Eight-edge evidence chain evaluated independently per country.
- No edge definitions were modified after collection began.
- Source coverage was recorded separately from traceability status.
Internally red-team reviewed
- No inference gaps in flagship claims.
- Evidence-to-claim binding checked for source discipline.
- Confidence grades matched available evidence quality.
- No first-ever claim without explicit caveats.
Frozen sample: 10 countries
The sample was selected to represent diversity in income class, WHO region and source coverage environment.
GhanaBangladeshSri LankaNigeriaIndiaThailandUnited KingdomEthiopiaPhilippinesPeru
Limitations
- Sample size: 10 countries, not globally representative.
- English-language sources only for this public review.
- Not assessed means no identifiable public evidence, not failure.
- No causal attribution: traceability is not implementation quality.
Reproducibility package: source locators, evidence spans and reasoning notes are documented in an evidence ledger. Full package available upon request: research@agentbrain.ch
AgentBrain process
How the intelligence was produced.
AgentBrain is a research and coordination system. Every finding in this review is produced through a structured process that separates collection, review, synthesis and publication approval.
Work can be delegated without delegating evidence control.
1
Objective
Human-defined research question and success criteria.
2
Alpha
Research agent with memory, goals and evidence discipline.
3
Specialist workers
Parallel evidence collection, extraction and verification.
4
Evidence review
Structured binding of claims to sources with confidence grades.
5
Controlled synthesis
Review before any public-facing claim is made.
6
Publication human gate
No public release without explicit human approval.
What AgentBrain is
Persistent memory across sessions, goal tracking, structured evidence storage, confidence grades, source locators, red-team review and explicit human approval for public outputs.
What this review is not
Not a real-time surveillance system, not a causal inference engine, not an automated AMR monitor and not a replacement for WHO GLASS or national reporting systems.
About this release
Public evidence review: methodology v2.1. Research base: ALPHA-MEGA-001 v1.0.1, frozen. Status: public evidence review. Contact: research@agentbrain.ch
Public evidence review: methodology v2.1. Research base: ALPHA-MEGA-001 v1.0.1, frozen. Status: public evidence review. Contact: research@agentbrain.ch